Home
About Us
- Our Services
- Our Hospitals
Research and Trials
Information for Patients
- What Our Patients Say
- Quality Management
Contact Us

CML

Our research and trials staff are dedicated and experienced professionals, interested in pushing the boundaries of our knowledge and testing new ideas in practical environments. Use the links below to jump to categorised trials.

SPIRIT2
Type:	NCRI, multi-centre phase III randomised trial
Eligibility:	Newly diagnosed CML in chronic phase Age >18 years
Study details:	Compares Imatinib 400 vs Dasatanib 100

Search for:
Pages
Staff Area
- Log in
More Links
- Cookie Settings

Department of Haematology and Stem Cell Transplantation

We are using cookies to give you the best experience on our website. You can find out more about which cookies we are using or switch them off in settings.

Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.

Strictly Necessary Cookies

Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.

disable

If you disable this cookie, we will not be able to save your preferences. This means that every time you visit this website you will need to enable or disable cookies again.

3rd Party Cookies

This website uses Google Analytics to collect anonymous information such as the number of visitors to the site, and the most popular pages.

Keeping this cookie enabled helps us to improve our website.

disable

Please enable Strictly Necessary Cookies first so that we can save your preferences!

CML

Pages

Staff Area

More Links